company background image
4013

Dr. Sulaiman Al Habib Medical Services Group SASE:4013 Stock Report

Last Price

ر.س210.20

Market Cap

ر.س73.6b

7D

-2.6%

1Y

14.9%

Updated

19 Aug, 2022

Data

Company Financials +
4013 fundamental analysis
Snowflake Score
Valuation1/6
Future Growth4/6
Past Performance6/6
Financial Health5/6
Dividends1/6

4013 Stock Overview

Dr. Sulaiman Al Habib Medical Services Group Company establishes, manages, and operates hospitals, general and specialized medical complexes, day surgery centers, and pharmaceutical facilities in Saudi Arabia.

Rewards

Earnings are forecast to grow 10.52% per year

Earnings grew by 20.6% over the past year

Risk Analysis

No risks detected for 4013 from our risk checks.

Dr. Sulaiman Al Habib Medical Services Group Competitors

Price History & Performance

Summary of all time highs, changes and price drops for Dr. Sulaiman Al Habib Medical Services Group
Historical stock prices
Current Share Priceر.س210.20
52 Week Highر.س230.00
52 Week Lowر.س148.00
Beta0.94
1 Month Change4.68%
3 Month Change-3.13%
1 Year Change14.86%
3 Year Changen/a
5 Year Changen/a
Change since IPO292.16%

Recent News & Updates

Aug 08
Why Dr. Sulaiman Al Habib Medical Services Group Company (TADAWUL:4013) Could Be Worth Watching

Why Dr. Sulaiman Al Habib Medical Services Group Company (TADAWUL:4013) Could Be Worth Watching

Let's talk about the popular Dr. Sulaiman Al Habib Medical Services Group Company ( TADAWUL:4013 ). The company's...

Jul 12
Dr. Sulaiman Al Habib Medical Services Group (TADAWUL:4013) Has More To Do To Multiply In Value Going Forward

Dr. Sulaiman Al Habib Medical Services Group (TADAWUL:4013) Has More To Do To Multiply In Value Going Forward

If you're looking for a multi-bagger, there's a few things to keep an eye out for. Amongst other things, we'll want to...

May 31
Does Dr. Sulaiman Al Habib Medical Services Group (TADAWUL:4013) Deserve A Spot On Your Watchlist?

Does Dr. Sulaiman Al Habib Medical Services Group (TADAWUL:4013) Deserve A Spot On Your Watchlist?

For beginners, it can seem like a good idea (and an exciting prospect) to buy a company that tells a good story to...

May 17
A Look At The Fair Value Of Dr. Sulaiman Al Habib Medical Services Group Company (TADAWUL:4013)

A Look At The Fair Value Of Dr. Sulaiman Al Habib Medical Services Group Company (TADAWUL:4013)

Today we will run through one way of estimating the intrinsic value of Dr. Sulaiman Al Habib Medical Services Group...

Shareholder Returns

4013SA HealthcareSA Market
7D-2.6%-3.0%-2.0%
1Y14.9%15.1%19.2%

Return vs Industry: 4013 matched the SA Healthcare industry which returned 15.1% over the past year.

Return vs Market: 4013 underperformed the SA Market which returned 19.2% over the past year.

Price Volatility

Is 4013's price volatile compared to industry and market?
4013 volatility
4013 Average Weekly Movement3.2%
Healthcare Industry Average Movement4.6%
Market Average Movement4.9%
10% most volatile stocks in SA Market8.2%
10% least volatile stocks in SA Market3.1%

Stable Share Price: 4013 is less volatile than 75% of SA stocks over the past 3 months, typically moving +/- 3% a week.

Volatility Over Time: 4013's weekly volatility (3%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
1993n/aNasser Mohammed Al Haqbanihttps://www.hmg.com

Dr. Sulaiman Al Habib Medical Services Group Company establishes, manages, and operates hospitals, general and specialized medical complexes, day surgery centers, and pharmaceutical facilities in Saudi Arabia. The company operates maternity, and orthopedics and spinal surgeries hospitals. It also operates dermatology, plastic surgery, ophthalmology, obesity treatment, and fertility centers, as well as pharmacies.

Dr. Sulaiman Al Habib Medical Services Group Fundamentals Summary

How do Dr. Sulaiman Al Habib Medical Services Group's earnings and revenue compare to its market cap?
4013 fundamental statistics
Market Capر.س73.57b
Earnings (TTM)ر.س1.52b
Revenue (TTM)ر.س7.81b

48.4x

P/E Ratio

9.4x

P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report
4013 income statement (TTM)
Revenueر.س7.81b
Cost of Revenueر.س5.26b
Gross Profitر.س2.55b
Other Expensesر.س1.02b
Earningsر.س1.52b

Last Reported Earnings

Jun 30, 2022

Next Earnings Date

n/a

Earnings per share (EPS)4.35
Gross Margin32.59%
Net Profit Margin19.47%
Debt/Equity Ratio55.6%

How did 4013 perform over the long term?

See historical performance and comparison

Dividends

1.6%

Current Dividend Yield

71%

Payout Ratio
We’ve recently updated our valuation analysis.

Valuation

Is 4013 undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score

1/6

Valuation Score 1/6

  • Price-To-Earnings vs Peers

  • Price-To-Earnings vs Industry

  • Price-To-Earnings vs Fair Ratio

  • Below Fair Value

  • Significantly Below Fair Value

  • Analyst Forecast

Key Valuation Metric

Which metric is best to use when looking at relative valuation for 4013?

Other financial metrics that can be useful for relative valuation.

4013 key valuation metrics and ratios. From Price to Earnings, Price to Sales and Price to Book to Price to Earnings Growth Ratio, Enterprise Value and EBITDA.
Key Statistics
Enterprise Value/Revenue9.5x
Enterprise Value/EBITDA39.8x
PEG Ratio4.6x

Price to Earnings Ratio vs Peers

How does 4013's PE Ratio compare to its peers?

4013 PE Ratio vs Peers
The above table shows the PE ratio for 4013 vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
CompanyPEEstimated GrowthMarket Cap
Peer Average59.5x
4002 Mouwasat Medical Services
40.4x13.6%ر.س23.5b
4004 Dallah Healthcare
36.5x14.6%ر.س10.5b
4007 Al Hammadi Company For Development and Investment
45.8x5.0%ر.س6.6b
4009 Middle East Healthcare
115.2x32.7%ر.س3.1b
4013 Dr. Sulaiman Al Habib Medical Services Group
48.4x10.5%ر.س73.6b

Price-To-Earnings vs Peers: 4013 is good value based on its Price-To-Earnings Ratio (48.4x) compared to the peer average (59.5x).


Price to Earnings Ratio vs Industry

How does 4013's PE Ratio compare vs other companies in the Asian Healthcare Industry?

Price-To-Earnings vs Industry: 4013 is expensive based on its Price-To-Earnings Ratio (48.4x) compared to the SA Healthcare industry average (38.5x)


Price to Earnings Ratio vs Fair Ratio

What is 4013's PE Ratio compared to its Fair PE Ratio? This is the expected PE Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

4013 PE Ratio vs Fair Ratio.
Fair Ratio
Current PE Ratio48.4x
Fair PE Ration/a

Price-To-Earnings vs Fair Ratio: Insufficient data to calculate 4013's Price-To-Earnings Fair Ratio for valuation analysis.


Share Price vs Fair Value

What is the Fair Price of 4013 when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Below Fair Value: 4013 (SAR210.2) is trading above our estimate of fair value (SAR186.74)

Significantly Below Fair Value: 4013 is trading above our estimate of fair value.


Analyst Price Targets

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

Analyst Forecast: Target price is lower than the current share price.


Discover undervalued companies

Future Growth

How is Dr. Sulaiman Al Habib Medical Services Group forecast to perform in the next 1 to 3 years based on estimates from 6 analysts?

Future Growth Score

4/6

Future Growth Score 4/6

  • Earnings vs Savings Rate

  • Earnings vs Market

  • High Growth Earnings

  • Revenue vs Market

  • High Growth Revenue

  • Future ROE


10.5%

Forecasted annual earnings growth

Earnings and Revenue Growth Forecasts


Analyst Future Growth Forecasts

Earnings vs Savings Rate: 4013's forecast earnings growth (10.5% per year) is above the savings rate (8.9%).

Earnings vs Market: 4013's earnings (10.5% per year) are forecast to grow faster than the SA market (0.9% per year).

High Growth Earnings: 4013's earnings are forecast to grow, but not significantly.

Revenue vs Market: 4013's revenue (13.1% per year) is forecast to grow faster than the SA market (-1.6% per year).

High Growth Revenue: 4013's revenue (13.1% per year) is forecast to grow slower than 20% per year.


Earnings per Share Growth Forecasts


Future Return on Equity

Future ROE: 4013's Return on Equity is forecast to be high in 3 years time (28.5%)


Discover growth companies

Past Performance

How has Dr. Sulaiman Al Habib Medical Services Group performed over the past 5 years?

Past Performance Score

6/6

Past Performance Score 6/6

  • Quality Earnings

  • Growing Profit Margin

  • Earnings Trend

  • Accelerating Growth

  • Earnings vs Industry

  • High ROE


19.0%

Historical annual earnings growth

Earnings and Revenue History

Quality Earnings: 4013 has high quality earnings.

Growing Profit Margin: 4013's current net profit margins (19.5%) are higher than last year (18.7%).


Past Earnings Growth Analysis

Earnings Trend: 4013's earnings have grown by 19% per year over the past 5 years.

Accelerating Growth: 4013's earnings growth over the past year (20.6%) exceeds its 5-year average (19% per year).

Earnings vs Industry: 4013 earnings growth over the past year (20.6%) exceeded the Healthcare industry 0.6%.


Return on Equity

High ROE: 4013's Return on Equity (26.6%) is considered high.


Discover strong past performing companies

Financial Health

How is Dr. Sulaiman Al Habib Medical Services Group's financial position?

Financial Health Score

5/6

Financial Health Score 5/6

  • Short Term Liabilities

  • Long Term Liabilities

  • Debt Level

  • Reducing Debt

  • Debt Coverage

  • Interest Coverage

Financial Position Analysis

Short Term Liabilities: 4013's short term assets (SAR4.4B) exceed its short term liabilities (SAR2.2B).

Long Term Liabilities: 4013's short term assets (SAR4.4B) exceed its long term liabilities (SAR3.8B).


Debt to Equity History and Analysis

Debt Level: 4013's net debt to equity ratio (7.6%) is considered satisfactory.

Reducing Debt: 4013's debt to equity ratio has increased from 26.6% to 55.6% over the past 5 years.

Debt Coverage: 4013's debt is well covered by operating cash flow (69.9%).

Interest Coverage: 4013's interest payments on its debt are well covered by EBIT (56.8x coverage).


Balance Sheet


Discover healthy companies

Dividend

What is Dr. Sulaiman Al Habib Medical Services Group current dividend yield, its reliability and sustainability?

Dividend Score

1/6

Dividend Score 1/6

  • Notable Dividend

  • High Dividend

  • Stable Dividend

  • Growing Dividend

  • Earnings Coverage

  • Cash Flow Coverage


1.64%

Current Dividend Yield

Dividend Yield vs Market

Notable Dividend: 4013's dividend (1.64%) isn’t notable compared to the bottom 25% of dividend payers in the SA market (1.86%).

High Dividend: 4013's dividend (1.64%) is low compared to the top 25% of dividend payers in the SA market (4.2%).


Stability and Growth of Payments

Stable Dividend: Whilst dividend payments have been stable, 4013 has been paying a dividend for less than 10 years.

Growing Dividend: 4013's dividend payments have increased, but the company has only paid a dividend for 2 years.


Earnings Payout to Shareholders

Earnings Coverage: With its reasonable payout ratio (71.1%), 4013's dividend payments are covered by earnings.


Cash Payout to Shareholders

Cash Flow Coverage: With its high cash payout ratio (126%), 4013's dividend payments are not well covered by cash flows.


Discover strong dividend paying companies

Management

How experienced are the management team and are they aligned to shareholders interests?

0.6yrs

Average management tenure


CEO

Nasser Mohammed Al Haqbani

no data

Tenure

ر.س230,000

Compensation

Mr. Nasser Mohammed Abdulaziz Al Haqbani has been Chief Executive Officer and Executive Member of Board at Dr. Sulaiman Al Habib Medical Services Group Company since December 10, 2018 and also serves as it...


Leadership Team

Experienced Management: 4013's management team is not considered experienced ( 0.6 years average tenure), which suggests a new team.


Board Members

Experienced Board: 4013's board of directors are considered experienced (3.7 years average tenure).


Ownership

Who are the major shareholders and have insiders been buying or selling?


Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.


Ownership Breakdown

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.


Top Shareholders

Company Information

Dr. Sulaiman Al Habib Medical Services Group Company's employee growth, exchange listings and data sources


Key Information

  • Name: Dr. Sulaiman Al Habib Medical Services Group Company
  • Ticker: 4013
  • Exchange: SASE
  • Founded: 1993
  • Industry: Health Care Facilities
  • Sector: Healthcare
  • Implied Market Cap: ر.س73.570b
  • Shares outstanding: 350.00m
  • Website: https://www.hmg.com

Number of Employees


Location

  • Dr. Sulaiman Al Habib Medical Services Group Company
  • King Fahad Road
  • Olaya District
  • Riyadh
  • 11372
  • Saudi Arabia

Listings


Company Analysis and Financial Data Status

All financial data provided by Standard & Poor's Capital IQ.
DataLast Updated (UTC time)
Company Analysis2022/08/19 00:00
End of Day Share Price2022/08/18 00:00
Earnings2022/06/30
Annual Earnings2021/12/31


Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.